Shah Tushar 4
4 · Liquidia Corp · Filed Nov 12, 2021
Insider Transaction Report
Form 4
Liquidia CorpLQDA
Shah Tushar
CMO and Head of R&D
Transactions
- Tax Payment
Common Stock
2021-11-12$5.04/sh−487$2,457→ 50,763 total - Tax Payment
Common Stock
2021-11-12$4.90/sh−11,882$58,204→ 38,881 total - Exercise/Conversion
Common Stock
2021-11-10+51,250→ 51,250 total - Award
Performance Stock Units
2021-11-10−51,250→ 0 total→ Common Stock (51,250 underlying)
Footnotes (2)
- [F1]Each performance stock unit (PSU) converts into one share of common stock of the Issuer.
- [F2]On January 19, 2021, the reporting person was granted 51,250 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861.